170 related articles for article (PubMed ID: 2551973)
1. Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases.
Katz BZ; Raab-Traub N; Miller G
J Infect Dis; 1989 Oct; 160(4):589-98. PubMed ID: 2551973
[TBL] [Abstract][Full Text] [Related]
2. Use of cloned probes to detect Epstein-Barr viral DNA in tissues of patients with neoplastic and lymphoproliferative diseases.
Andiman W; Gradoville L; Heston L; Neydorff R; Savage ME; Kitchingman G; Shedd D; Miller G
J Infect Dis; 1983 Dec; 148(6):967-77. PubMed ID: 6317774
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus--determined clonality in posttransplant lymphoproliferative disease.
Patton DF; Wilkowski CW; Hanson CA; Shapiro R; Gajl-Peczalska KJ; Filipovich AH; McClain KL
Transplantation; 1990 Jun; 49(6):1080-4. PubMed ID: 2163133
[TBL] [Abstract][Full Text] [Related]
4. Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization.
Saemundsen AK; Purtilo DT; Sakamoto K; Sullivan JL; Synnerholm AC; Hanto D; Simmons R; Anvret M; Collins R; Klein G
Cancer Res; 1981 Nov; 41(11 Pt 1):4237-42. PubMed ID: 6272968
[TBL] [Abstract][Full Text] [Related]
5. In situ hybridization for Epstein-Barr virus NotI repeats in posttransplant lymphoproliferative disorder.
Montone KT; Friedman H; Hodinka RL; Hicks DG; Kant JA; Tomaszewski JE
Mod Pathol; 1992 May; 5(3):292-302. PubMed ID: 1323104
[TBL] [Abstract][Full Text] [Related]
6. Presence of the diffuse early antigen of Epstein-Barr virus in lymphomas and lymphoproliferative disorders.
Katz BZ; Saini U
Am J Pathol; 1992 May; 140(5):1247-54. PubMed ID: 1316087
[TBL] [Abstract][Full Text] [Related]
7. Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation.
Rea D; Fourcade C; Leblond V; Rowe M; Joab I; Edelman L; Bitker MO; Gandjbakhch I; Suberbielle C; Farcet JP
Transplantation; 1994 Aug; 58(3):317-24. PubMed ID: 8053055
[TBL] [Abstract][Full Text] [Related]
8. Comparison of polymerase chain reaction and standard Southern blotting for the detection of Epstein-Barr virus DNA in various biopsy specimens.
Pedneault L; Katz BZ
J Med Virol; 1993 Jan; 39(1):33-43. PubMed ID: 8380841
[TBL] [Abstract][Full Text] [Related]
9. The impact of EBV hybridization in clinical and biological medicine.
Morinet F
Nouv Rev Fr Hematol (1978); 1989; 31(2):155-8. PubMed ID: 2549502
[TBL] [Abstract][Full Text] [Related]
10. Replicative viral DNA in Epstein-Barr virus associated Burkitt's lymphoma biopsies.
Gutierrez MI; Bhatia K; Magrath I
Leuk Res; 1993 Mar; 17(3):285-9. PubMed ID: 8383779
[TBL] [Abstract][Full Text] [Related]
11. Clonal analysis of posttransplant lymphoproliferative disorders, using both episomal Epstein-Barr virus and immunoglobulin genes as markers.
Kaplan MA; Ferry JA; Harris NL; Jacobson JO
Am J Clin Pathol; 1994 May; 101(5):590-6. PubMed ID: 8178765
[TBL] [Abstract][Full Text] [Related]
12. Presence of Epstein-Barr virus latency type III at the single cell level in post-transplantation lymphoproliferative disorders and AIDS related lymphomas.
Brink AA; Dukers DF; van den Brule AJ; Oudejans JJ; Middeldorp JM; Meijer CJ; Jiwa M
J Clin Pathol; 1997 Nov; 50(11):911-8. PubMed ID: 9462239
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
Leong IT; Fernandes BJ; Mock D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
[TBL] [Abstract][Full Text] [Related]
14. Differential cellular susceptibility to Epstein-Barr virus infection in a patient with X-linked lymphoproliferative disease.
Okano M; Thiele GM; Gross TG; Davis JR; Purtilo DT
J Med Virol; 1990 Sep; 32(1):47-52. PubMed ID: 2173737
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection.
Ho M; Miller G; Atchison RW; Breinig MK; Dummer JS; Andiman W; Starzl TE; Eastman R; Griffith BP; Hardesty RL
J Infect Dis; 1985 Nov; 152(5):876-86. PubMed ID: 2995512
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr-virus-associated lymphoproliferative syndrome in severe combined immunodeficiency: establishment of a lymphoblastoid cell line as an in vitro model for biological and therapeutic studies.
Simon M; Borisch B; Heymer B
Acta Haematol; 1996; 96(3):170-7. PubMed ID: 8876615
[TBL] [Abstract][Full Text] [Related]
17. Demonstration of Epstein-Barr viral DNA in paraffin-embedded specimens of lymphoproliferative syndrome. Evidence for a productive infection comparable to lymphoblastoid cell lines.
Simon M; Neumann R; Bültmann B
Pathol Res Pract; 1992 Feb; 188(1-2):106-14. PubMed ID: 1317554
[TBL] [Abstract][Full Text] [Related]
18. Biomolecular analysis of a defective nontransforming Epstein-Barr virus (EBV) from a patient with chronic active EBV infection.
Alfieri C; Joncas JH
J Virol; 1987 Oct; 61(10):3306-9. PubMed ID: 3041050
[TBL] [Abstract][Full Text] [Related]
19. Synchronous and sequential activation of latently infected Epstein-Barr virus genomes.
Takada K; Ono Y
J Virol; 1989 Jan; 63(1):445-9. PubMed ID: 2462063
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus integration in human lymphomas and lymphoid cell lines.
Gulley ML; Raphael M; Lutz CT; Ross DW; Raab-Traub N
Cancer; 1992 Jul; 70(1):185-91. PubMed ID: 1318776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
